SCHEMBL824616

SCHEMBL824616

Cc1cc2c(C)c(C)c(C)c(C)c2c(=O)[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.43
KDM4E B2RXH2 5/20 0.42
GAA P10253 4/20 0.42
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
MAPK1 P28482 1/20 0.38
CA1 P00915 1/20 0.37
ACVR1 Q04771 1/20 0.36
ALDH1A1 P00352 4/20 0.35
GLA P06280 2/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LPO P22079 1/20 0.34
PTGS1 P23219 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP1A2 P05177 1/20 0.34
PKM P14618 1/20 0.34
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11144846 0.70 KDM4E (0.38) PARP1KDM4EGAAPDE3BPDE3A
SCHEMBL8265173 0.67 MAPK1 (0.54) PARP1KDM4EGAAMAPK1CA1
SCHEMBL2617518 0.67 PDE3B (0.36) KDM4EGAAPDE3BPDE3AMAPK1
SCHEMBL13757238 0.67 GAA (0.37) PARP1KDM4EGAAPDE3BPDE3A
SCHEMBL25658490 0.65 KDM4E (0.57) PARP1KDM4EGAACA1ALDH1A1
SCHEMBL31049021 0.65 GAA (0.39) PARP1KDM4EGAAPDE3BPDE3A
SCHEMBL14363715 0.64 CYP1A2 (0.31) CYP1A2
SCHEMBL22699207 0.64 PARP1 (0.46) PARP1KDM4EGAAMAPK1CA1
SCHEMBL11976387 0.64 KDM4E (0.53) PARP1KDM4EGAAMAPK1CA1
SCHEMBL16454953 0.63 SGK1 (0.39) PARP1GAAMAPK1CA1GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143274-B2 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2012-03-27 US disclosed
US-20070185160-A1 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185160-A1 1-(2H)-isoquinolone derivative NR3C2, NR1H4, NR3C1 PARP1 4305/4885KDM4E 2949/4885GAA 4558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.